Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Active“
Suchtreffer
Begriffe & Kennungen
Abasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbiraterone Mylan · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Women who are
Eintrag öffnenAblymico · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAblymico · 4.5 · No interaction study has been performed. A clinically relevant interaction with active substances with poor so
Eintrag öffnenAbnormal radioactive iodine uptake test result
Eintrag öffnenAbnormale Konzentration des zirkulierenden C-reaktiven Proteins
Eintrag öffnenAbraxane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbrysvo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAbseamed · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAccumulation of muscle fiber desmin
Eintrag öffnenAclasta · 4.3 · - Hypersensitivity to the active substance, to any bisphosphonates or to any of the excipients listed in secti
Eintrag öffnenActos · 4.3 · - hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - cardiac failure
Eintrag öffnenActraphane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenActraphane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenActrapid · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnen